ConductScience.org, home

Paper55647

A 5-year controlled study of B.C.G. and radiotherapy inoperable lung cancer.

Pines A. Lancet, 1976. Cited by 38 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. A 5-year controlled study of B.C.G. and radiotherapy inoperable lung cancer. Papers, record 55647. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/55647

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A 5-year controlled study of B.C.G. and radiotherapy inoperable lung cancer.
PubMed
Journal
Lancet
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
1.76
iCite
Revised in PubMed
2019-06-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pines AA

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BCG VaccineMajor topic
Carcinoma, Squamous CellMajor topic
Lung NeoplasmsMajor topic
Aged
Cyclophosphamide
Follow-Up Studies
Humans
Male
Middle Aged
Myocardial Infarction
Neoplasm Metastasis
Neoplasm Recurrence, Local
Palliative Care
Time Factors

Source PubMed

Download CSV of topics

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
31788476Is the Combination of Immunotherapy and Radiotherapy in Non-small Cell Lung Cancer a Feasible and Effective Approach?Front Med (Lausanne)2019https://conductscience.org/library/papers/31788476PubMed
7039148Specific and nonspecific immunotherapy as an adjunct to curative surgery for cancer of the lung.Yale J Biol Med1981https://conductscience.org/library/papers/7039148PubMed
793085Immunology of bronchial carcinoma.Thorax1976https://conductscience.org/library/papers/793085PubMed
466592Oral administration of BCG as an adjuvant to surgical treatment of carcinoma of the bronchus.Can Med Assoc J1979https://conductscience.org/library/papers/466592PubMed
375459Anticoagulants in the treatment of small cell carcinoma of the bronchus.Thorax1979https://conductscience.org/library/papers/375459PubMed
272083Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.World J Surg1977https://conductscience.org/library/papers/272083PubMed
184810BCG treatment of malignant pleural effusions in the rat.Br J Cancer1976https://conductscience.org/library/papers/184810PubMed
146331[Combination chemotherapy in patients with disseminated bronchogenic carcinoma (author's transl)].Z Krebsforsch Klin Onkol Cancer Res Clin Oncol1977https://conductscience.org/library/papers/146331PubMed
119598In vivo effect of levamisole on cellular and humoral immunity in normal chickens.Clin Exp Immunol1979https://conductscience.org/library/papers/119598PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/55647

GET https://conductscience.org/api/papers/v1/55647/authors